YAP1 and prostate carcinoma: However, these experimental data were supported by human patient data only in pancreatic cancer (75), breast cancer (76), and prostate cancer (77); where YAP or TAZ expression and nuclear localization is increased in metastatic tumors when compared to primary tumors.